{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:51:49Z","timestamp":1786373509456,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,7]]},"abstract":"\n Background and objectives<\/jats:title>\n Secondary hyperparathyroidism is common among patients with ESRD. Although medical therapy for secondary hyperparathyroidism has changed dramatically over the last decade, rates of parathyroidectomy for secondary hyperparathyroidism across the United States population are unknown. We examined temporal trends in rates of parathyroidectomy, in-hospital mortality, length of hospital stay, and costs of hospitalization.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n Using the Healthcare Cost and Utilization Project\u2019s Nationwide Inpatient Sample, a representative national database on hospital stay regardless of age and payer in the United States, we identified parathyroidectomies for secondary hyperparathyroidism from 2002 to 2011. Data from the US Renal Data System reports were used to calculate the rate of parathyroidectomy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n We identified 32,971 parathyroidectomies for secondary hyperparathyroidism between 2002 and 2011. The overall rate of parathyroidectomy was approximately 5.4\/1000 patients (95% confidence interval [95% CI], 5.0\/1000 to 6.0\/1000). The rate decreased from 2003 (7.9\/1000 patients; 95% CI, 6.2\/1000 to 9.6\/1000), reached a nadir in 2005 (3.3\/1000 patients; 95% CI, 2.6\/1000 to 4.0\/1000), increased again through 2006 (5.4\/1000 patients; 95% CI, 4.4\/1000 to 6.4\/1000), and remained stable since that time. Rates of in-hospital mortality decreased from 1.7% (95% CI, 0.8% to 2.6%) in 2002 to 0.8% (95% CI, 0.1% to 1.6%) in 2011 (\n P<\/jats:italic>\n for trend <0.001). In\u2013hospital mortality rates were significantly higher in patients with heart failure (odds ratio [OR], 4.23; 95% CI, 2.59 to 6.91) and peripheral vascular disease (OR, 4.59; 95% CI, 2.75 to 7.65) and lower among patients with prior kidney transplantation (OR, 0.20; 95% CI, 0.06 to 0.65).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Despite the use of multiple medical therapies, rates of parathyroidectomy of secondary hyperparathyroidism have not declined in recent years.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.10370915","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T23:04:17Z","timestamp":1465254257000},"page":"1260-1267","source":"Crossref","is-referenced-by-count":93,"title":["Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States"],"prefix":"10.2215","volume":"11","author":[{"given":"Sun Moon","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Long","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine,"},{"name":"Division of Pediatric Nephrology, Department of Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Montez-Rath","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine,"},{"name":"Division of Pediatric Nephrology, Department of Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Norton","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"B1-20230816","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230816","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B3-20230816","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B4-20230816","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1523-1755.2004.00368.x","article-title":"Parathyroidectomy rates among United States dialysis patients: 1990-1999","volume":"65","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"B5-20230816","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1681\/ASN.2004020138","article-title":"The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230816","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2010.10.041","article-title":"Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007","volume":"57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B7-20230816","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20230816","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2014.04.014","article-title":"Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D","volume":"64","author":"Yusuf","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B9-20230816","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"B10-20230816","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1744-9987.2011.00994.x","article-title":"Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients","volume":"15","author":"El-Shafey","year":"2011","journal-title":"Ther Apher Dial"},{"key":"B11-20230816","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"B13-20230816","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V1261242","article-title":"Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study","volume":"12","author":"Malberti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B16-20230816","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2369-14-100","article-title":"Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends","volume":"14","author":"Lafrance","year":"2013","journal-title":"BMC Nephrol"},{"key":"B17-20230816","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"B18-20230816","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B19-20230816","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"B20-20230816","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000350213","article-title":"Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients","volume":"37","author":"Kilpatrick","year":"2013","journal-title":"Am J Nephrol"},{"key":"B21-20230816","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","article-title":"Cinacalcet and achievement of the NKF\/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study","volume":"24","author":"Ure\u00f1a","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B22-20230816","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ki.2013.289","article-title":"AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients","volume":"85","author":"Martin","year":"2014","journal-title":"Kidney Int"},{"key":"B23-20230816","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1185\/03007995.2015.1031731","article-title":"A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"31","author":"Bell","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B24-20230816","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"B25-20230816","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.03520414","article-title":"Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis","volume":"10","author":"Ishani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26-20230816","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2015.72","article-title":"Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"88","author":"Komaba","year":"2015","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:32Z","timestamp":1786369592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,6]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10370915","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,6]]}}}